Cambridge Investment Research Advisors, Inc.
Position in INSP — Inspire Medical Systems, Inc.
CIK 1419186
FAIRFIELD, IA
Position in INSP
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$386,947
-$774,413 QoQ
Shares Held
8,674
-31.1% QoQ
Ownership
0.030%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#140
of 274 holders
Holding Since
Dec 2021
9 quarters on record
Common Shares in INSP Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Cambridge Investment Research Advisors, Inc. holds $94,085,440 across 27 Medical Devices names. INSP ranks #18 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
299,079 | $27,138,428 | |
| 2 | SYK |
Stryker Corp
|
73,172 | $23,037,472 | |
| 3 | MDT |
Medtronic plc
|
241,056 | $18,857,810 | |
| 4 | GEHC |
GE HealthCare Technologies Inc.
|
82,290 | $5,267,382 | |
| 5 | EW |
Edwards Lifesciences Corp
|
45,749 | $4,138,454 | |
| 6 | DXCM |
Dexcom Inc
|
45,009 | $3,031,356 | |
| 7 | BSX |
Boston Scientific Corp
|
51,066 | $2,179,496 | |
| 8 | STE |
STERIS plc
|
7,965 | $1,677,190 |
All Filings in INSP
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $386,947 | 8,674 | Shares | Sole | 2026-07-30 | |
| 2025-12-31 | $1,161,360 | 12,592 | Shares | Sole | 2026-02-05 | |
| 2023-06-30 | $354,831 | 1,093 | Shares | Sole | 2023-07-13 | |
| 2023-03-31 | $308,738 | 1,319 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $566,478 | 2,249 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $253,461 | 1,429 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $204,225 | 1,118 | Shares | Sole | 2022-07-13 | |
| 2022-03-31 | $267,984 | 1,044 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $309,430 | 1,345 | Shares | Sole | 2022-02-03 | |
| No filing history on record for this holder in this stock. | ||||||